Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
Tiziana Life Sciences Plc |
LSE:TILS |
London |
Ordinary Share |
GB00BKWNZY55 |
ORD 3P |
|
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
|
1.00 |
0.96% |
105.00 |
107.00 |
110.00 |
112.50 |
103.50 |
103.50 |
1,326,160 |
16:35:13 |
Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
Pharmaceuticals & Biotechnology |
0.0 |
-7.8 |
-5.4 |
- |
204 |
Tiziana Life Sciences Share Discussion Threads

Showing 12551 to 12572 of 14950 messages
Date | Subject | Author | Discuss |
---|
21/1/2021 17:54 | I doubt 50p is expected.
But 'Once the Big RNS drops' - what happens in the instance 'Efficacy' is not as expected considering it is a human trial?
OldApache, is it difficult to understand that myself, SC & Andy are not one and the same buddy but ignorance can be bliss, I do understand! |  rebelwithacause1 | |
21/1/2021 17:23 | He's buying accustem shares at 50p mate someone tell the stupid alias of Rebelwithoutabrain that the board hasn't been set up yet perhaps next month?This board is about how great things will look once that big RNS lands.look at te pipe line that tils will roll out.Foralumab is the world's first and only, fully human anti-CD3 antibody and can be delivered orally, making it a potential game changer in the treatment of Crohn's Disease and other autoimmune diseases through higher efficacy and reduced toxicity.Foralumab modulates the immune response, reducing inflammation locally and systemically, through interaction with the gastrointestinal and nasal mucosal immune system.Market opportunities....COVIDNASHRAPSORIASISLUPUSMSIBDGVHDRemember many of these conditions are treat via IV... We will offer nasal and oral option.... Less side effects... Reduced costs! |  mark0419 | |
21/1/2021 16:40 | I'm buying at 50p. |  small crow | |
21/1/2021 16:19 | I understand the excuse man but please dont try and 'Pull the wool over our eyes' - there are many on here much smarter than yourself! |  rebelwithacause1 | |
21/1/2021 16:17 | hehe! still on the naughty step little buddypoo |  yidarmytom | |
21/1/2021 16:11 | Not downbeat, just objective to all things TLSA but I still await your answer to my question 'Mr BioPharma', I hope its not too complex but considering that you have vast experience within the sphere...how many pre-clinical trials have demonstrated safety adequacy and then faltered?...
No time like the present to hear your thoughts buddy! |  rebelwithacause1 | |
21/1/2021 16:01 | rebs still on the naughty step (Filtered) but for someone who is Long he/she is incredibly downbeat about the Co's prospects I have to say hehe! |  yidarmytom | |
21/1/2021 15:45 | that video now on ggp share board , a good example for other shares |  bunz3 | |
21/1/2021 15:45 | that video now on ggp share board , a good example for other shares |  bunz3 | |
21/1/2021 15:42 | 230p still possible or would you like to re-evaluate OldApache - you silly mug!
Keep listening to such educated and proficient investors...but remember the 'Champ' doesn't rule supreme for no reason! |  rebelwithacause1 | |
21/1/2021 14:57 | Big move to the 'Big Boys Playground' but Big sells with trial results imminent, Big sentiment wouldn't you say or is that 'Efficacy' may not be as the 'Herds' expect!
Decisions, decisions, just don't get caught with your 'Shirt' hey! |  rebelwithacause1 | |
21/1/2021 14:36 | Hehe - I have to say its such a privilege listening to you OldApache! - much love buddy...
Have you still not realised yet that with the 'Champs' profound knowledge, I cover all bases so its hard to reciprocate but all valued opinions welcome anytime you're ready, I do look forward to it! |  rebelwithacause1 | |
21/1/2021 14:30 | Your just making a fool of yourself now Reb..... Wonder what it's like to be so disliked. Banished from LSE and now no one listening to your constant down beat forecasts about Tils. You can't even go down the pub to find a friend. Lol |  mark0419 | |
21/1/2021 13:40 | The herds still continue to reiterate the same with a man's 'Best Friend' Twitter - I ask again how many pre-clinical trials have demonstrated safety adequacy and then faltered?
But billions and trillions are still highly likely right with such ferocious competition within BioPharma...Globally! |  rebelwithacause1 | |
21/1/2021 13:26 | https://twitter.com/astrobrook/status/1352119103100772353?s=21 |  aaron_r | |
21/1/2021 12:10 | 'HOPE' being the given word!
I can hope for 'Everything' but it is not guaranteed now is it!
...But you still continue to miss the point or just resistant to listening. I iterate again (and no doubt will again!) - how many trials are abandoned following expansion due to untoward instances? - quite a few by my recollection! |  rebelwithacause1 | |
21/1/2021 12:07 | hope to see very positive clinical trial data so we can expand the trial |  yidarmytom | |
21/1/2021 12:02 | Confidence diminishing hey, I thought its just started, surely I'm not mistaken am I! |  rebelwithacause1 | |
21/1/2021 11:58 | it's been a fun engagement but we're at the end of the road bud |  yidarmytom | |
21/1/2021 11:48 | Brilliant buddy - I'm most grateful...
...But when you do 'Unfilter' not if realise I'm not SC but if you still don't believe it, read over both our comments and 'DisSect' the information as appropriate as they would in a clinical setting like yours, it may just help you realise that we are both very different... |  rebelwithacause1 | |
21/1/2021 11:43 | rebs filtered, small crow filtered |  yidarmytom | |
21/1/2021 11:32 | Hehe - seriously Tom, you would rather listen to the 'Mug' that is OldApache and all his palava...that is worrying! |  rebelwithacause1 | |